T. Rowe Price Associates, Inc. 13D and 13G filings for KESTRA MEDICAL TECHNOLOGIES, LTD.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 10:26 am Purchase | 2025-12-31 | 13G | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS | T. Rowe Price Associates, Inc. | 4,369,429 7.500% | 4,369,429 (New Position) | Filing |